Daily Intelligence Brief
Depo-Provera Sets a Firm-Concentrated Filing Pace
The day’s leading intake clustered in a handful of established product-liability dockets, with Depo-Provera (3140) setting the pace at 11 filings as Murphy Law Firm submitted three and Hochman Law Firm PLLC two. Social Media Adolescent Addiction (3047) also logged nine, six from Keller Postman LLC and one from Brockstedt Mandalas Federico LLC, while Hair Relaxer (3060) matched that count behind three filings each from Peiffer Wolf and Singleton Schreiber LLP. The Johnson & Johnson Talcum Powder (2738) docket added eight matters, with Morgan & Morgan PA and Napoli Shkolnik contributing two each, a broader firm mix than the day’s more concentrated leaders. Aqueous Film-Forming Foams (2873) completed the top tier with three complaints, all filed by Clancy Fleishman LLP, keeping the environmental docket in the day’s high-volume group despite its smaller count. Across the five, the pattern is not a single-docket spike but targeted repeat intake by firms already active in drug, platform, consumer-product, and environmental cases. See the full filing feed and firm-level breakdowns here.
Michigan Appeals Court Restores Childhood-Abuse Claim Against Grand Rapids Church
On July 14, 2026, the Michigan Court of Appeals reinstated Marian Ippel’s childhood sexual-abuse suit against Grace Christian Reformed Church of Grand Rapids and the Christian Reformed Church in North America, returning the case to Kent County Circuit Court. The lower court had dismissed the 2024 action as untimely, but the appellate ruling applied Michigan’s later legislative changes extending the civil filing window for childhood sexual-abuse survivors. Ippel alleges abuse in 2006 and 2007, when she was three and four years old; the ruling restores the claim without resolving those allegations on the merits. The decision gives plaintiffs and institutions a current appellate marker on the scope of Michigan’s revised limitations regime for historic abuse claims.
Missouri Roundup Settlement Hearing Moves Into View
A Missouri Circuit Court final-approval hearing on the proposed Roundup class settlement is set for August 19, 2026. The proposed agreement is designed to resolve current and potential future non-Hodgkin lymphoma claims, and its opt-out and objection period has closed. The hearing will determine whether the settlement becomes effective; it will not decide whether glyphosate caused any individual plaintiff’s injury. For Roundup Products Liability Litigation (2741), the state-court process is a distinct settlement track rather than new merits activity in the federal proceeding. The scheduled court date is the next concrete checkpoint for counsel weighing the agreement’s scope and future-claim treatment.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.